2004
DOI: 10.1016/j.tetlet.2003.11.055
|View full text |Cite
|
Sign up to set email alerts
|

Asymmetric synthesis of macrolactin analogue

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
13
0

Year Published

2008
2008
2016
2016

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(15 citation statements)
references
References 33 publications
2
13
0
Order By: Relevance
“…Takemoto and co-workers have reported the enantioselective synthesis of macrolactin A analogues in which an alkyne to 1,3-diene isomerization was used to prepare a key intermediate (Scheme 22). 43,44 In this case, the formed (E,E)-1,3-diene itself is a structural element of the final product and the activating carbonyl group is reduced to a chiral alcohol. In this work the optimal catalyst for the isomerization of alkynone 49 was found to be bis(diphenylphosphine)butane (DPPB), rather than triphenylphosphine.…”
Section: Scheme 17mentioning
confidence: 99%
“…Takemoto and co-workers have reported the enantioselective synthesis of macrolactin A analogues in which an alkyne to 1,3-diene isomerization was used to prepare a key intermediate (Scheme 22). 43,44 In this case, the formed (E,E)-1,3-diene itself is a structural element of the final product and the activating carbonyl group is reduced to a chiral alcohol. In this work the optimal catalyst for the isomerization of alkynone 49 was found to be bis(diphenylphosphine)butane (DPPB), rather than triphenylphosphine.…”
Section: Scheme 17mentioning
confidence: 99%
“…So far, at least 30 MLNs have been reported, among which macrolactin A (MLN A, 1a) and 7-O-succinyl macrolactin A (SMA) are at present in preclinical evaluation as antimacular degeneration and antitumor agents (Bae et al, 2014). Due to their promising bioactivity and unique structure, many efforts have been devoted to chemical syntheses of MLNs (Smith and Ott, 1998;Marino et al, 2002;Kobayashi et al, 2004). Bacillaenes (BAEs) are polyene antibiotics originally discovered from the fermentation broth of Bacillus subtilis as bacteriostatic agents (Patel et al, 1995) (Fig.…”
Section: Introductionmentioning
confidence: 99%
“…sunhua in the soil of a potato cultivation area (5) and was produced by a soil Streptomyces species (6) and by Bacillus amyloliquefaciens FZB42 (7). Because of their unreliable supply from cell culture, structural uniqueness, and broad therapeutic potential, MA and macrolactin analogs have been attractive targets for asymmetric syntheses (8). Indeed, macrolactins A and E have been chemically synthesized (9)(10)(11).…”
mentioning
confidence: 99%
“…MA and SMA also exhibited excellent antibacterial activities on intestinal vancomycin-resistant enterococci colonization in mice (4). MA has a broad spectrum of activity, with significant antiviral and cancer cell cytotoxic properties, including inhibition of B16-F10 murine melanoma cell replication and mammalian herpes simplex viruses (1,8). MA has been shown to protect lymphoblast cells against HIV by inhibiting viral replication (1).…”
mentioning
confidence: 99%